These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9753069)

  • 1. The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Keating S; de Witte T; Suciu S; Willemze R; Hayat M; Labar B; Resegotti L; Ferrini PR; Caronia F; Dardenne M; Solbu G; Petti MC; Vegna ML; Mandelli F; Zittoun RA
    Br J Haematol; 1998 Sep; 102(5):1344-53. PubMed ID: 9753069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A Study of the Leukemia Cooperative Group of the EORTC and GIMEMA. European Organization for Research and Treatment of Cancer (EORTC) Leukemia Cooperative Group and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA).
    Keating S; de Witte T; Suciu S; Mandelli F; Damasio E; Willemze R; Morra E; Amadori S; Dardenne M; Vegna ML; Zittoun RA
    Eur J Cancer; 1999 Oct; 35(10):1440-7. PubMed ID: 10673975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups.
    Keating S; Suciu S; de Witte T; Mandelli F; Willemze R; Resegotti L; Broccia G; Thaler J; Labar B; Damasio E; Bizzi B; Rotoli B; Vekhoff A; Muus P; Petti MC; Dardenne M; Solbu G; Vegna ML; Zittoun RA
    Bone Marrow Transplant; 1996 Jun; 17(6):993-1001. PubMed ID: 8807105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
    Zittoun RA; Mandelli F; Willemze R; de Witte T; Labar B; Resegotti L; Leoni F; Damasio E; Visani G; Papa G
    N Engl J Med; 1995 Jan; 332(4):217-23. PubMed ID: 7808487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921).
    Oosterveld M; Suciu S; Verhoef G; Labar B; Belhabri A; Aul C; Selleslag D; Ferrant A; Wijermans P; Mandelli F; Amadori S; Jehn U; Muus P; Zittoun R; Hess U; Anak O; Beeldens F; Willemze R; de Witte T
    Leukemia; 2003 May; 17(5):859-68. PubMed ID: 12750698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial.
    Suciu S; Mandelli F; de Witte T; Zittoun R; Gallo E; Labar B; De Rosa G; Belhabri A; Giustolisi R; Delarue R; Liso V; Mirto S; Leone G; Bourhis JH; Fioritoni G; Jehn U; Amadori S; Fazi P; Hagemeijer A; Willemze R;
    Blood; 2003 Aug; 102(4):1232-40. PubMed ID: 12714526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
    Hengeveld M; Suciu S; Karrasch M; Specchia G; Marie JP; Muus P; Petti MC; Rotoli B; Amadori S; Fioritoni G; Leoni P; Morra E; Thaler J; Resegotti L; Fazi P; Vignetti M; Mandelli F; Zittoun R; de Witte T
    Ann Hematol; 2012 Jun; 91(6):825-35. PubMed ID: 22460947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
    Gorin NC; Labopin M; Fouillard L; Meloni G; Frassoni F; Iriondo A; Brunet Mauri S; Goldstone AH; Harousseau JL; Reiffers J; Esperou-Bourdeau H; Gluckman E
    Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA/AIEOP experience. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Associazione Italiana Ematologìa ed Ocologia Pediatrica.
    Giona F; Testi AM; Annino L; Amadori S; Arcese W; Camera A; Di Montezemolo LC; Ladogana S; Liso V; Meloni G
    Br J Haematol; 1994 Jan; 86(1):55-61. PubMed ID: 8011548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties.
    Burnett AK; Goldstone AH; Stevens RM; Hann IM; Rees JK; Gray RG; Wheatley K
    Lancet; 1998 Mar; 351(9104):700-8. PubMed ID: 9504514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.
    Amadori S; Testi AM; Aricò M; Comelli A; Giuliano M; Madon E; Masera G; Rondelli R; Zanesco L; Mandelli F
    J Clin Oncol; 1993 Jun; 11(6):1046-54. PubMed ID: 8501490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT.
    Hengeveld M; Suciu S; Chelgoum Y; Marie JP; Muus P; Lefrère F; Mandelli F; Pane F; Amadori S; Fioritoni G; Labar B; Baron F; Cermak J; Bourhis JH; Storti G; Fazi P; Hagemeijer A; Vignetti M; Willemze R; de Witte T
    Bone Marrow Transplant; 2015 Mar; 50(3):341-7. PubMed ID: 25402418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
    Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Liso V; Iacopino P; Avvisati G; Petti MC; Broccia G; Carotenuto M; Falda M; Fazi P; Lazzarino M; Leoni P; Mirto S; Pucci G; Nobile F; Nosari AM; Specchia G; Stasi R; Tabilio A; Mandelli F
    Leukemia; 1996 Sep; 10(9):1443-52. PubMed ID: 8751460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous or allogeneic bone marrow transplantation for acute myeloblastic leukemia in second complete remission. Importance of duration of first complete remission in final outcome.
    Tomás F; Gómez-García de Soria V; López-Lorenzo JL; Arranz R; Figuera A; Cámara R; Alegre A; Fernández-Rañada JM
    Bone Marrow Transplant; 1996 Jun; 17(6):979-84. PubMed ID: 8807103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study.
    Thomas X; Suciu S; Rio B; Leone G; Broccia G; Fillet G; Jehn U; Feremans W; Meloni G; Vignetti M; de Witte T; Amadori S
    Haematologica; 2007 Mar; 92(3):389-96. PubMed ID: 17339189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
    Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 therapy in relapsed acute myelogenous leukemia.
    Meloni G; Vignetti M; Pogliani E; Invernizzi R; Allione B; Mirto S; Sica S; Leoni F; Selleri C; Mandelli F
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S43-7. PubMed ID: 9457393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Access to bone marrow transplantation in acute myeloblastic leukemia. Study of 52 patients treated in a single center].
    Tomás JF; Calvo JM; Gómez-García de Soria V; Pinilla I; Figuera A; Fernández-Rañada JM
    Med Clin (Barc); 1997 May; 109(1):12-5. PubMed ID: 9303971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.